Cefea Sp. z o.o. sp.k
Cefea Sp. z o.o. sp.k is recorded as a service provider in 8 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 8 of 8 trials · Latest update first
A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of Allopurinol on the Risk of Cardiovascular Events in Patients With High and Very High Cardiovascular Risk, Including the Presence of Long-COVID Syndrome.
Sponsor Uniwersytet Medyczny Im. Karola Marcinkowskiego W Poznaniu
- Start (EU)
- Latest update
- Estimated end
- Not reported
A multicenter, randomized, blinded, placebo controlled, phase II study to evaluate the safety and efficacy of cell therapy based with artificially expanded CD4+CD25+CD127- regulatory lymphocytes and anti-CD20 antibody in pediatric patients with presymptomatic diabetes type 1 (stage 1)
Sponsor Poltreg S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A multicentre, randomised, double-blind, placebo-controlled phase III study, evaluating the effect of dapagliflozin on prevention of cardiotoxicity in breast cancer patients undergoing anthracycline-based chemotherapy (PROTECTAA).
Sponsor 4 Wojskowy Szpital Kliniczny Z Polikliniką Samodzielny Publiczny Zaklad Opieki Zdrowotnej We Wroclawiu
- Start (EU)
- Latest update
- Estimated end
- Not reported
An Open-label Multicenter Rollover Study to Provide Continued Treatment to Participants Previously Enrolled in a RVU120 Clinical Study
Sponsor Ryvu Therapeutics S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Evaluation of the efficacy of topical treatment with budesonide in children with Crohn's disease located in the esophagus and/or stomach and/or duodenum - BETHESDa
Sponsor Medical University Of Warsaw
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomized, double-blind, placebo-controlled trial evaluating efficacy and safety of dimethyl fumarate in brain atrophy reduction, synaptic functional connectivity, cognitive functions, quality of life, and activity of daily living improvement among patients with mild cognitive impairment and dementia due to Alzheimer’s disease
Sponsor Medical University Of Lodz
- Start (EU)
- Latest update
- Estimated end
- Not reported
Optimal medical treatment of uncontrolled hypertension. OPTIMAL-HT
Sponsor Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase 2a non-commercial and non-randomized intervention study evaluating the efficacy of crizotinib in the treatment of children with severe type 2 neurofibromatosis, in particular those excluded from surgery and / or radiotherapy
Sponsor Medical University Of Warsaw
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Cefea Sp. z o.o. sp.k?
The 2026-10-09 snapshot links Cefea Sp. z o.o. sp.k to 8 distinct CTIS trials. Recorded services include Medicinal product management, Packaging, labeling, and delivery of the IMP, IMP release, 1. repackaging of IMPs 2. storage of IMPs 3. labelling of IMPs 4. release of IMPs for clinical trial 5. Transport of IMPs 6. Disposal of IMPs, drug product/placebo: packiging, labeling and release of clinical batch, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Cefea Sp. z o.o. sp.k?
The most frequently recorded therapeutic areas are Cardiology, Endocrinology, Immunology, Infectious Disease. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Cefea Sp. z o.o. sp.k conducted?
The linked trials record locations in 4 countries, including Poland, Spain, France, Italy. These are trial locations, not confirmed office locations or countries where Cefea Sp. z o.o. sp.k delivered services.
What can this page tell me about Cefea Sp. z o.o. sp.k's trial experience?
Browse 8 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Cefea Sp. z o.o. sp.k. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Cefea Sp. z o.o. sp.k.